Cargando…

Structurally modified compounds of hydroxychloroquine, remdesivir and tetrahydrocannabinol against main protease of SARS-CoV-2, a possible hope for COVID-19: Docking and molecular dynamics simulation studies

Now a days, more than 200 countries faces the health crisis due to epidemiological disease COVID-19 caused by SARS-CoV-2 virus. It will cause a very high impact on world’s economy and global health sector. Earlier the structure of main protease (M(pro)) protein was deposited in the RCSB protein repo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mishra, Deepak, Maurya, Radha Raman, Kumar, Kamlesh, Munjal, Nupur S., Bahadur, Vijay, Sharma, Sandeep, Singh, Prashant, Bahadur, Indra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051003/ https://www.ncbi.nlm.nih.gov/pubmed/33879934 http://dx.doi.org/10.1016/j.molliq.2021.116185

Ejemplares similares

Xanthene based hybrid analogues to inhibit protease of novel corona Virus: Molecular docking and ADMET studies
por: Kumar Vishvakarma, Vijay, et al.
Publicado: (2020)

Interactions between main protease of SARS-CoV-2 and testosterone or progesterone using computational approach
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2022)

L-amino-acids as immunity booster against COVID-19: DFT, molecular docking and MD simulations
por: Singh, Prashant, et al.
Publicado: (2022)

Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations
por: Vishvakarma, Vijay Kumar, et al.
Publicado: (2021)

Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19
por: Hussein, R.K., et al.
Publicado: (2021)

In silico study of remdesivir with and without ionic liquids having different cations using DFT calculations and molecular docking
por: Kumari, Kamlesh, et al.
Publicado: (2022)

Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach
por: Shahabadi, Nahid, et al.
Publicado: (2021)

Hydroxychloroquine (HCQ): real treatment or false hope?
por: El Bakkouri, Karim
Publicado: (2021)

An In Silico investigation for acyclovir and its derivatives to fight the COVID-19: Molecular docking, DFT calculations, ADME and td-Molecular dynamics simulations
por: Babu Singh, Madhur, et al.
Publicado: (2022)

Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2020)

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022)

Novel antiviral effects of chloroquine, hydroxychloroquine, and green tea catechins against SARS CoV-2 main protease (Mpro) and 3C-like protease for COVID-19 treatment
por: Shaik, Fareeda Begum, et al.
Publicado: (2022)

Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
por: Cardoso, Wesley B., et al.
Publicado: (2021)

Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries
por: Adhikari, Sugat, et al.
Publicado: (2020)

Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease
por: Marinho, Emanuelle Machado, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations
por: Masand, Vijay H., et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020)

In silico analyses of major active constituents of fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme
por: Bahadur Gurung, Arun, et al.
Publicado: (2022)

Molecular docking identification for the efficacy of natural limonoids against COVID-19 virus main protease
por: de Oliveira, Victor Moreira, et al.
Publicado: (2021)

Molecular docking and dynamics simulation of main protease of SARS-CoV-2 with naproxen derivative
por: K Hussein, Rageh, et al.
Publicado: (2023)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

Protein-DNA docking with a coarse-grained force field
por: Setny, Piotr, et al.
Publicado: (2012)

Computer-generated “synthetic contingency” plans at times of logistics and supply problems: scenarios for hydroxychloroquine and remdesivir
por: Szymkuć, Sara, et al.
Publicado: (2020)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients
por: Arribas, Jose Ramon, et al.
Publicado: (2020)

Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
por: Voit, Katja, et al.
Publicado: (2021)

COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels
por: Szendrey, Mark, et al.
Publicado: (2021)

Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study
por: Reyaz, Saima, et al.
Publicado: (2021)

Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis()
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021)

Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations
por: Nguyen, Hoang Linh, et al.
Publicado: (2020)

Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease
por: Belhassan, Assia, et al.
Publicado: (2020)

Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking
por: Cheng, Bijun, et al.
Publicado: (2020)

Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020)

Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
por: Omer, Samia E., et al.
Publicado: (2022)

Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease
por: Owis, Asmaa I., et al.
Publicado: (2020)

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
por: Maciorowski, Dawid, et al.
Publicado: (2020)

Continuous-Flow Synthesis of Δ(9)-Tetrahydrocannabinol and Δ(8)-Tetrahydrocannabinol from Cannabidiol
por: Bassetti, Benedetta, et al.
Publicado: (2023)

Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study
por: Sargolzaei, Mohsen
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nm834moghapaepgu68ckmodqoq